SAVANNAH MCDANIEL: Open Payments
NPI 1831512540 · OCEAN SPRINGS, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 31 payments from 13 companies in 2025. Trend: 2023 $904 · 2024 $881 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| Merck Sharp & Dohme LLC | 7 | $148 |
| Boston Scientific Corporation | 1 | $142 |
| Novartis Pharmaceuticals Corporation | 6 | $122 |
| Edwards Lifesciences Corporation | 1 | $61 |
| Amgen Inc. | 3 | $48 |
| E.R. Squibb & Sons, L.L.C. | 3 | $48 |
| SCPHARMACEUTICALS INC. | 2 | $34 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $33 |
| Regeneron Healthcare Solutions, Inc. | 1 | $30 |
| Alnylam Pharmaceuticals Inc. | 1 | $27 |
Products named: General - Structural Heart, VERQUVO, LEQVIO, PASCAL, REPATHA, FUROSCIX, CAMZYOS, Kerendia.
Industry payments across MS — which companies pay providers there.
